Original Research
Accepted on 06 Mar 2026
Recombinant human adenovirus type 5 synergizes with anti-PD-L1 antibody to promote anti-hepatocellular carcinoma effects through multilevel remodeling of the immune microenvironment
in Cancer Immunity and Immunotherapy